Medications

Added benefit of sucroferric oxyhydroxide is not proven

Sucroferric oxyhydroxide (trade name Velphoro) has been approved since August 2014 for adults with chronic kidney disease on haemodialysis or peritoneal dialysis. The German Institute for Quality and Efficiency in Health ...

Diseases, Conditions, Syndromes

Emergency aid for overdoses

Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently. It can also be used for dialysis ...

Immunology

Fight against organ failure advances

(Medical Xpress)—The findings of a 20-year project undertaken by scientists committed to developing improved treatments for chronic kidney disease reveal a significant advance in our understanding of organ failure.

Diseases, Conditions, Syndromes

Home dialysis gains momentum

Of the 400,000 people on dialysis in the United States only 6 percent to 7 percent are treated with home dialysis. Yet, patients are significantly more likely to choose home dialysis if they are given that option. Home dialysis ...

page 4 from 6